Pollack I F, Mulvihill J J
Department of Neurological Surgery, Children's Hospital of Pittsburgh, Pennsylvania, USA.
J Neurooncol. 1996 May-Jun;28(2-3):257-68. doi: 10.1007/BF00250204.
Neurofibromatosis 1 (NF1) is a common multisystem disorder that is frequently associated with neoplastic and non-neoplastic lesions within the central nervous system. Improvements in neuroimaging have led to increased detection of both types of lesions. Focal areas of increased T2 signal represent the most common abnormalities detected. The vast majority of such lesions are non-neoplastic and fluctuate in number and size during childhood. Optic pathway tumors are second in frequency and generally manifest an indolent natural history, although some lesions will increase in size over time and lead to progressive visual impairment. A smaller percentage of patients will develop gliomas within the cerebral and cerebellar hemispheres of brain-stem. This article will review areas of controversy in the evaluation and follow-up of patients with NF1 and will present our approach to these issues. We will also discuss therapeutic considerations in these patients that take into account the unique features of the underlying disorder.
神经纤维瘤病1型(NF1)是一种常见的多系统疾病,常与中枢神经系统内的肿瘤性和非肿瘤性病变相关。神经影像学的进步使得这两种类型病变的检出率有所提高。T2信号增强的局灶性区域是最常见的检出异常。绝大多数此类病变是非肿瘤性的,在儿童期数量和大小会波动。视神经通路肿瘤的发生率次之,通常表现为惰性的自然病程,尽管有些病变会随着时间推移而增大并导致进行性视力损害。较小比例的患者会在脑干的大脑和小脑半球内发生胶质瘤。本文将回顾NF1患者评估和随访中的争议领域,并介绍我们对这些问题的处理方法。我们还将讨论这些患者的治疗考虑因素,同时兼顾潜在疾病的独特特征。